|Market Research A to Z | Company Profiles A to Z | Register | Contact Us|
|+44 (0) 203 086 8600 Call us on|
Pfizer Inc. announced today financial results for first quarter 2012. Revenues for the first quarter were $15.4 billion, a decrease of 7%compared with $16.5 billion in the 2011 quarter, which reflects an operational decline of $1.0 billion, or 6%, and the unfavourable impact of foreign exchange of $57 million, or less than 1%.
For first quarter 2012, US revenues were $6.0 billion, a decrease of 15% compared with the 2011 quarter, primarily as a result of the US loss of exclusivity of Lipitor on November 30, 2011. International revenues were $9.5 billion, consistent with the prior-year quarter, which reflects 1% operational growth and a 1% unfavourable impact of foreign exchange.
US revenues represented 39% of total revenues in first-quarter 2012 compared with 43% in the 2011 quarter, while international revenues represented 61% of total revenues in first-quarter 2012 compared with 57% in the 2011 quarter.
"I am pleased with our first-quarter 2012 financial performance, which was driven primarily by growth in certain brands including Celebrex, Enbrel and Lyrica, growth in key geographies such as China, as well as our continued ability to realize cost savings and efficiently allocate our shareholders' capital," said Ian Read, Chairman and Chief Executive Officer
Emerging Markets unit revenues grew 9% operationally in comparison with first-quarter 2011, primarily due to continued volume growth across the product portfolio, predominantly in China. Nutrition unit revenues also had China to thank for an increase of 8% operationally in comparison with the same quarter last year, driven by the continued benefits from successful new product launches and increased promotional activities.
For more information on the Healthcare industry, see the latest research: Healthcare Reports
Follow us on Twitter @CandMResearch
Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.